Amarillo National Bank maintained its stake in Colgate-Palmolive Company (NYSE:CL) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,434 shares of the company’s stock at the end of the 2nd quarter. Amarillo National Bank’s holdings in Colgate-Palmolive were worth $551,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Blue Chip Partners Inc. lifted its position in shares of Colgate-Palmolive by 0.4% during the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after purchasing an additional 8 shares during the last quarter. M Holdings Securities Inc. lifted its position in shares of Colgate-Palmolive by 0.4% during the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after purchasing an additional 21 shares during the last quarter. Capital Investment Advisors LLC lifted its position in shares of Colgate-Palmolive by 0.3% during the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after purchasing an additional 27 shares during the last quarter. Savant Capital LLC lifted its position in shares of Colgate-Palmolive by 0.3% during the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock worth $770,000 after purchasing an additional 30 shares during the last quarter. Finally, Smith Moore & CO. lifted its position in shares of Colgate-Palmolive by 0.3% during the first quarter. Smith Moore & CO. now owns 10,373 shares of the company’s stock worth $759,000 after purchasing an additional 32 shares during the last quarter. Institutional investors and hedge funds own 73.10% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Amarillo National Bank Has $551,000 Stake in Colgate-Palmolive Company (CL)” was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/09/25/amarillo-national-bank-has-551000-stake-in-colgate-palmolive-company-cl.html.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $72.41, for a total transaction of $277,547.53. Following the completion of the transaction, the insider now owns 53,022 shares in the company, valued at $3,839,323.02. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the transaction, the chief operating officer now owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 217,969 shares of company stock valued at $15,693,933. Corporate insiders own 1.02% of the company’s stock.

Several analysts have recently weighed in on the company. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating in a research report on Monday. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 target price for the company in a research report on Monday. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Deutsche Bank AG reiterated a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a research report on Monday, July 24th. Finally, Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $75.62.

Shares of Colgate-Palmolive Company (CL) traded up 3.60% during trading on Monday, hitting $73.75. The stock had a trading volume of 3,410,848 shares. The company’s 50 day moving average price is $71.58 and its 200 day moving average price is $73.27. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market cap of $64.96 billion, a price-to-earnings ratio of 27.41 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. The firm had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter last year, the company earned $0.70 earnings per share. Equities research analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.